MCRB - Seres Therapeutics Q1 2024 Earnings Preview
2024-05-07 14:04:56 ET
More on Seres Therapeutics
- Seres Therapeutics, Inc. (MCRB) Q4 2023 Earnings Call Transcript
- Seres Therapeutics GAAP EPS of -$0.89 beats by $0.10, revenue of $126.33M beats by $0.23M
- Seeking Alpha’s Quant Rating on Seres Therapeutics
- Historical earnings data for Seres Therapeutics
- Financial information for Seres Therapeutics